The G Protein-Coupled Receptor GPR17: Overview and Update.
Article Details
- CitationCopy to clipboard
Marucci G, Dal Ben D, Lambertucci C, Santinelli C, Spinaci A, Thomas A, Volpini R, Buccioni M
The G Protein-Coupled Receptor GPR17: Overview and Update.
ChemMedChem. 2016 Dec 6;11(23):2567-2574. doi: 10.1002/cmdc.201600453. Epub 2016 Nov 14.
- PubMed ID
- 27863043 [ View in PubMed]
- Abstract
The GPR17 receptor is a G protein-coupled receptor (GPCR) that seems to respond to two unrelated families of endogenous ligands: nucleotide sugars (UDP, UDP-galactose, and UDP-glucose) and cysteinyl leukotrienes (LTD4 , LTC4 , and LTE4 ), with significant affinity at micromolar and nanomolar concentrations, respectively. This receptor has a broad distribution at the level of the central nervous system (CNS) and is found in neurons and in a subset of oligodendrocyte precursor cells (OPCs). Unfortunately, disparate results emerging from different laboratories have resulted in a lack of clarity with regard to the role of GPR17-targeting ligands in OPC differentiation and in myelination. GPR17 is also highly expressed in organs typically undergoing ischemic damage and has various roles in specific phases of adaptations that follow a stroke. Under such conditions, GPR17 plays a crucial role; in fact, its inhibition decreases the progression of ischemic damage. This review summarizes some important features of this receptor that could be a novel therapeutic target for the treatment of demyelinating diseases and for repairing traumatic injury.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Galactose-uridine-5'-diphosphate Uracil nucleotide/cysteinyl leukotriene receptor Protein Humans UnknownRegulatorDetails Uridine diphosphate glucose Uracil nucleotide/cysteinyl leukotriene receptor Protein Humans UnknownRegulatorDetails Uridine-5'-Diphosphate Uracil nucleotide/cysteinyl leukotriene receptor Protein Humans UnknownRegulatorDetails